A citation-based method for searching scientific literature

Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
Times Cited: 81

Hyeyeun Lim, Susan S Devesa, Julie A Sosa, David Check, Cari M Kitahara. JAMA 2017
Times Cited: 744

List of shared articles

Times cited

TERT Promoter Mutations and the 8th Edition TNM Classification in Predicting the Survival of Thyroid Cancer Patients.
Jun Park, Sungjoo Lee, Kyunga Kim, Hyunju Park, Chang-Seok Ki, Young Lyun Oh, Jung Hee Shin, Jee Soo Kim, Sun Wook Kim, Jae Hoon Chung,[...]. Cancers (Basel) 2021

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy.
Jierui Liu, Yanqing Liu, Yansong Lin, Jun Liang. Endocrinol Metab (Seoul) 2019

The Increased Risk of Thyroid Cancer-Specific Mortality With Tumor Size in Stage IVB Patients.
Junyi Zhang, Xiaoyun Cheng, Bin Su, Xingchun Wang, Lu Wang, Muthukumaran Jayachandran, Xiaoting Sun, Le Bu, Yueye Huang, Shen Qu. Front Oncol 2020

Regulators of the RAS-ERK pathway as therapeutic targets in thyroid cancer.
Miguel A Zaballos, Adrián Acuña-Ruiz, Marta Morante, Piero Crespo, Pilar Santisteban. Endocr Relat Cancer 2019

The Coexistence of Genetic Mutations in Thyroid Carcinoma Predicts Histopathological Factors Associated With a Poor Prognosis: A Systematic Review and Network Meta-Analysis.
Ling Zhao, Lin Wang, Xiaomeng Jia, Xiaodong Hu, Ping Pang, Sitong Zhao, Yajing Wang, Jing Wang, Yingshi Zhang, Zhaohui Lyu. Front Oncol 2020

Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy.
Jinwei Hu, Isabella J Yuan, Saied Mirshahidi, Alfred Simental, Steve C Lee, Xiangpeng Yuan. Int J Mol Sci 2021

Coding Molecular Determinants of Thyroid Cancer Development and Progression.
Veronica Valvo, Carmelo Nucera. Endocrinol Metab Clin North Am 2019

Diagnosis and Management of Anaplastic Thyroid Cancer.
Ashish V Chintakuntlawar, Robert L Foote, Jan L Kasperbauer, Keith C Bible. Endocrinol Metab Clin North Am 2019

Loss of DNA methylation is related to increased expression of miR-21 and miR-146b in papillary thyroid carcinoma.
Isabella Maria Dias Payão Ortiz, Mateus Camargo Barros-Filho, Mariana Bisarro Dos Reis, Caroline Moraes Beltrami, Fabio Albuquerque Marchi, Hellen Kuasne, Luísa Matos do Canto, Julia Bette Homem de Mello, Cecilie Abildgaard, Clóvis Antônio Lopes Pinto,[...]. Clin Epigenetics 2018

Melatonin synergizes BRAF-targeting agent dabrafenib for the treatment of anaplastic thyroid cancer by inhibiting AKT/hTERT signalling.
Yina Liao, Yao Gao, An Chang, Zongjuan Li, Huayu Wang, Jing Cao, Wei Gu, Ranran Tang. J Cell Mol Med 2020